Issue navigation
Volume 56, Issue 12, December 2017
EDITORIALS
Thinking points for aching joints: Poetry on Rheumatology
Rheumatology, Volume 56, Issue 12, December 2017, Page 2041, https://doi.org/10.1093/rheumatology/kex296
Educating people with rare rheumatological conditions
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2042–2043, https://doi.org/10.1093/rheumatology/kew487
New use for tociluzimab in giant cell arteritis
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2044–2045, https://doi.org/10.1093/rheumatology/kew489
New viral outbreaks: time for rheumatologists to get involved? Chronic arthralgias and viral infections
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2046–2047, https://doi.org/10.1093/rheumatology/kex177
The multisystemic nature and natural history of joint hypermobility syndrome and Ehlers–Danlos syndrome in children: New research data conflict with widely held views
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2048–2049, https://doi.org/10.1093/rheumatology/kex241
REVIEWS
Adult Paget’s disease of bone: a review
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2050–2059, https://doi.org/10.1093/rheumatology/kew430
Ocular involvement in patients with spondyloarthritis
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2060–2067, https://doi.org/10.1093/rheumatology/kex057
CLINICAL SCIENCE
Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2068–2072, https://doi.org/10.1093/rheumatology/kex074
The natural history of children with joint hypermobility syndrome and Ehlers–Danlos hypermobility type: a longitudinal cohort study
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2073–2083, https://doi.org/10.1093/rheumatology/kex148
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2084–2092, https://doi.org/10.1093/rheumatology/kex234
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2093–2101, https://doi.org/10.1093/rheumatology/kex269
International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2102–2108, https://doi.org/10.1093/rheumatology/kex305
Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2109–2113, https://doi.org/10.1093/rheumatology/kex323
Antibodies to aquaporins are frequent in patients with primary Sjögren’s syndrome
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2114–2122, https://doi.org/10.1093/rheumatology/kex328
Validation of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2123–2128, https://doi.org/10.1093/rheumatology/kex324
Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2129–2134, https://doi.org/10.1093/rheumatology/kex332
Patellofemoral morphology is not related to pain using three-dimensional quantitative analysis in an older population: data from the Osteoarthritis Initiative
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2135–2144, https://doi.org/10.1093/rheumatology/kex329
The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2145–2153, https://doi.org/10.1093/rheumatology/kex340
Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2154–2161, https://doi.org/10.1093/rheumatology/kex352
Limited reliability of radiographic assessment of spinal progression in ankylosing spondylitis
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2162–2169, https://doi.org/10.1093/rheumatology/kex321
Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2170–2178, https://doi.org/10.1093/rheumatology/kex350
Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2179–2189, https://doi.org/10.1093/rheumatology/kex319
An increased concentration of receptor activator of nuclear factor kappa-B ligand pre-dates the onset of rheumatoid arthritis
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2190–2196, https://doi.org/10.1093/rheumatology/kex339
Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2197–2203, https://doi.org/10.1093/rheumatology/kex351
Trajectories of cardiorespiratory fitness in patients with juvenile dermatomyositis
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2204–2211, https://doi.org/10.1093/rheumatology/kex366
Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort study
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2212–2221, https://doi.org/10.1093/rheumatology/kex357
Disease activity decrease is associated with improvement in work productivity over 1 year in early axial spondyloarthritis (SPondyloArthritis Caught Early cohort)
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2222–2228, https://doi.org/10.1093/rheumatology/kex365
BASIC AND TRANSLATIONAL SCIENCE
The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2229–2236, https://doi.org/10.1093/rheumatology/kex360
LETTERS TO THE EDITOR
OTHER
An evaluation of the patient-administered Rheumatoid Arthritis Disease Activity Index for assessing disease activity during pregnancy
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2237–2239, https://doi.org/10.1093/rheumatology/kex364
CASE REPORTS
Synovitis acne pustulosis hyperostosis osteitis (SAPHO) – paradoxical reactions and different responses to tumour necrosis factor inhibitors
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2239–2241, https://doi.org/10.1093/rheumatology/kex309
Type I interferonopathy in a young adult
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2241–2243, https://doi.org/10.1093/rheumatology/kex316
The gouty spine: old guy—new tricks
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2243–2245, https://doi.org/10.1093/rheumatology/kex325
To distinguish IgG4-related disease from seronegative granulomatosis with polyangiitis
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2245–2247, https://doi.org/10.1093/rheumatology/kex335
CLINICAL VIGNETTES
Galaxy sign in alveolar sarcoidosis: An unusual radiological presentation of Lofgren’s syndrome
Rheumatology, Volume 56, Issue 12, December 2017, Page 2128, https://doi.org/10.1093/rheumatology/kex359
Immune checkpoint inhibitor-induced myo-fasciitis
Rheumatology, Volume 56, Issue 12, December 2017, Page 2161, https://doi.org/10.1093/rheumatology/kex369
GLOBAL NEWS ITEMS
NICE issues positive recommendation for XELJANZ®▼(tofacitinib citrate) as a new treatment option for adults with severe rheumatoid arthritis
Rheumatology, Volume 56, Issue 12, December 2017, Page e49, https://doi.org/10.1093/rheumatology/kex407
Global news: building a rheumatology team for East Africa
Rheumatology, Volume 56, Issue 12, December 2017, Page e50, https://doi.org/10.1093/rheumatology/kex409
EDITOR'S ACKNOWLEDGEMENT
Editor's Acknowledgement
Rheumatology, Volume 56, Issue 12, December 2017, Pages 2248–2254, https://doi.org/10.1093/rheumatology/kex416
CORRECTION NOTICES
Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Syndrome Registry
Rheumatology, Volume 56, Issue 12, December 2017, Page 2255, https://doi.org/10.1093/rheumatology/kex331
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
Rheumatology, Volume 56, Issue 12, December 2017, Page 2256, https://doi.org/10.1093/rheumatology/kex348
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs
Rheumatology, Volume 56, Issue 12, December 2017, Page 2257, https://doi.org/10.1093/rheumatology/kex389
Primary angiitis of the central nervous system—a territory about to be discovered
Rheumatology, Volume 56, Issue 12, December 2017, Page 2258, https://doi.org/10.1093/rheumatology/kex408
